Pregled bibliografske jedinice broj: 194552
Gastric pentadecapeptide BPC 157 - effective therapy of muscle crush injury in rat, given intraperitoneally or applied locally as a cream
Gastric pentadecapeptide BPC 157 - effective therapy of muscle crush injury in rat, given intraperitoneally or applied locally as a cream // 3. hrvatski kongres patologije i sudske medicine s međunarodnim sudjelovanjem : knjiga sažetaka
Opatija, Hrvatska, 2005. str. 94-94 (poster, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 194552 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Gastric pentadecapeptide BPC 157 - effective
therapy of muscle crush injury in rat, given
intraperitoneally or applied locally as a cream
Autori
Starešinić, Mario ; Novinšćak, Tomislav ; Batelja, Lovorka ; Brčić, Luka ; Jukić, Ivana ; Pevec, Dubravko ; Kokić, Neven ; Anić, Tomislav ; Buljat, Gojko ; Zoričić, Ivan ; Perović, Darko ; Sikirić, Predrag ; Seiwerth, Sven
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
3. hrvatski kongres patologije i sudske medicine s međunarodnim sudjelovanjem : knjiga sažetaka
/ - , 2005, 94-94
Skup
3. hrvatski kongres patologije i sudske medicine s međunarodnim sudjelovanjem
Mjesto i datum
Opatija, Hrvatska, 08.05.2005. - 11.05.2005
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
crush injury ; BPC 157 ; healing ; muscles
Sažetak
Stable gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, M.W. 1419 (PL-10, PLD-116, PL 14736 Pliva, Croatia)), accelerates healing of wounds, burns as well as transected Achilles tendon and shows strong anti-inflammatory effects. BPC is effective alone, without carrier, in trials for inflammatory bowel disease, wound treatment, locally or systemically, with no toxicity reported. We hypothesize that BPC 157 may have clinical relevance as both systemic and local peptide treatment of major muscle crush injury, such as gastrocnemius muscle complex (GCC). In crushed rats (GCC, impulse force 0.4653 Ns, kinetic energy 0.7217 J, force delivered 0.727 Ns/cm2) BPC 157 (without carrier) was applied intraperitoneally (10 μ g, 10 ng, 10 pg/kg) or locally (1.0 or 0.01 µ g (dissolved in distilled water)/g commercial neutral cream) (given only immediately after injury (sacrifice at 2h) and/or once daily, final 24 hours before sacrifice (at 4, 7, 14, 21, 28, 72 days)). Assessment was functional, macroscopical and histological. BPC 157 improves muscle healing: (i) functionally (walking test – sciatic functional index, and extensor postural thrust/motor function index show significant improvement), (ii) macroscopically (less hematoma and edema, smaller limb circumference), (iii) microscopically (less inflammation and fibrosis, more regeneration). Effective at any of the investigated intervals, BPC 157 induces post-injury muscle healing promptly and then maintains the healing with full function restoration.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
Napomena
Rad je kao poster prezentiran i na skupu 'Myology
2005', održanom od 09.-13.05.2005., Nantes,
Francuska ; uz međunarodnu recenziju objavljen u
Knjizi sazetaka ; str. 119-119.
POVEZANOST RADA
Projekti:
0108238
Ustanove:
Fakultet elektrotehnike i računarstva, Zagreb,
Medicinski fakultet, Zagreb
Profili:
Ivana Jukić
(autor)
Mario Starešinić
(autor)
Sven Seiwerth
(autor)
Dubravko Pevec
(autor)
Darko Perović
(autor)
Neven Kokić
(autor)
Luka Brčić
(autor)
Predrag Sikirić
(autor)
Gojko Buljat
(autor)
Tomislav Anić
(autor)